Table 1. Patient Demographics and Baseline Characteristics.
Variable | Frequency n (%) |
---|---|
Age, Mean (SD) | 63.2 years (14.7) |
Gender | |
Male | 119 (54.8%) |
Female | 98 (45.2%) |
Cancer Type / Site | |
Hematologic | 72 (33.2%) |
Genitourinary | 19 (8.8%) |
Lung | 19 (8.8%) |
Gastrointestinal | 18 (8.3%) |
Hepatopancreatobiliary | 16 (7.4%) |
Sarcoma | 15 (6.9%) |
Head and Neck | 14 (6.5%) |
Gynecologic | 14 (6.5%) |
Breast | 13 (6%) |
Other | 17 (7.8%) |
Mortality | |
Rate | 99 (45.6%) |
Median Time from Consult (range) | 36 days (3-372) |
Nutrition Screening* | |
Low Risk | 4 (1.8%) |
Moderate Risk | 25 (11.5%) |
High Risk | 179 (82.5%) |
Admitting Service | |
Medicine | 143 (65.9%) |
Surgery | 48 (22.1%) |
Intensive Care Unit | 14 (6.5%) |
Neurology | 12 (5.5%) |
Psychiatric Consult Diagnosis | |
Delirium/Cognitive Disorder | 131 (60.4%) |
Mood or Anxiety Disorder | 45 (20.7%) |
Adjustment Disorder | 35 (16.1%) |
Other | 6 (2.8%) |
Cancer Treatment** | |
Surgery*** | 42 (19.4%) |
Chemotherapy | 103 (47.5%) |
Radiation | 30 (13.8%) |
No Active Treatment | 71 (32.7%) |
SD = Standard deviation
Indicates that the sum is less than 100% due to missing data.
Sum is greater than 100% since patients may have received more than one type of treatment.
All surgeries were performed during the current admission and the median time from surgery to measurement of serum thiamine concentration was 8 days (range 1-43 days).